In The News

03.05.19

TCPA Litigation Remains Challenging for Policyholders

Manatt's Christine Reilly, leader of the consumer protection, advertising and competition practice, spoke to Business Insurance about a recent rise in litigation stemming from alleged violations of the Telephone Consumer Protection Act (TCPA).


03.04.19

Congress Considers Bipartisan Anti-Robocall Bill

Manatt’s Christine Reilly, leader of the firm’s consumer protection, advertising and competition practice, spoke to Bloomberg Law about a new measure in Congress aimed at cracking down on illegal robocallers.The TRACED Act by Sens. John Thune (R-South Dakota) and Ed Markey ...


02.28.19

Multiple Energy Technologies Sues Hologenix for False and Misleading Claims Regarding Celliant

Multiple Energy Technologies LLC, the maker of Redwave®-brand bioceramics, filed a lawsuit today in the United States District Court of California, Central District, against Hologenix LLC for making false and misleading claims about the Hologenix competing product, Celliant®, in violation ...


02.28.19

Michael Cohen Gives Testimony to Congress on Work With President Donald Trump

Manatt’s Jack Quinn, a partner in the government and regulatory practice, spoke to CNN about allegations made by President Donald Trump’s former attorney Michael Cohen against the president during testimony before members of Congress on February 27.


02.26.19

Governor Cuomo Rethinks Job Creation, Economy in New York After Amazon Fallout

Manatt’s Bruce Gyory, a senior advisor in the government and regulatory practice, spoke to City & State New York about Governor Andrew Cuomo and his approach to job creation and economic development. When asked whether New York “needs to overhaul its economic development ...


02.26.19

Major Film Studios Bring Suit Against Streaming Platform VidAngel Over Subscription Fees

Manatt’s Robert Jacobs, leader of the entertainment litigation practice, spoke to The Daily Journal about a recent lawsuit brought by a team of film studios against streaming video company VidAngel.


02.25.19

Pharmaceutical CEOs Testify Before Congress on Drug Pricing

Manatt’s Ian Spatz, a senior advisor with Manatt Health, spoke with CNBC ahead of a Senate Finance Committee hearing on February 26 in which CEOs from seven of the country’s largest pharmaceutical companies provided testimony about drug pricing in the U.S.


02.25.19

Rep. Schiff, House Democrats Ready to Subpoena Mueller if Report Not Made Public

Manatt’s Jack Quinn, a partner in the government and regulatory practice, appeared on CNN to comment on Rep. Adam Schiff 9 (D-CA)’s recent assertion that Congress will subpoena special counsel Robert Mueller to testify before the House Intelligence Committee if his report is not made ...


02.22.19

Roger Stone Comes Under Criticism for Instagram Posts About Criminal Case

Manatt’s Jack Quinn, a partner in the government and regulatory practice, appeared on CNN to speak about ongoing developments in Roger Stone’s criminal case.


02.21.19

Centers for Medicare & Medicaid Services Considers More Transparency in Pricing

Manatt’s Joel Ario, a managing director with Manatt Health, spoke to InsideHealthPolicy about a recent push from the Centers for Medicare & Medicaid Services (CMS) to increase price transparency in exchange plans.